Thomas schuetz compass therapeutics
WebCompass Therapeutics, Inc. is a clinical-stage, ... Compass Therapeutics's CEO is Thomas Schuetz How do I contact Compass Therapeutics? Compass Therapeutics contact info: … http://www.usaindiachamber.org/Dr-Thomas-Schuetz.php
Thomas schuetz compass therapeutics
Did you know?
WebCompass Therapeutics LLC employs 34 employees. The Compass Therapeutics LLC management team includes Thomas Schuetz (Co-Founder and CEO), Vered Bisker-Leib … WebJan 26, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Compass Therapeutics, Inc. (NASDAQ:CMPX) Co-Founder, Thomas Schuetz, recently …
WebCompany profile for Compass Therapeutics Inc. including key executives, insider ... and tumor growth. The company was founded by Thomas J. Schuetz on March 20, 2024 and … WebJan 26, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Compass Therapeutics, Inc. ( NASDAQ:CMPX...
WebMar 16, 2024 · Co-Founder & Chief Executive Officer at Compass Therapeutics . Dr. Schuetz has over 20 years of experience in oncology, biopharmaceutical drug development, ... WebApr 11, 2024 · In other Compass Therapeutics news, CEO Thomas J. Schuetz bought 20,000 shares of the company's stock in a transaction that occurred on Tuesday, January 31st. The stock was purchased at an average price of $4.05 per share, with a total value of $81,000.00.
WebApr 13, 2024 · Compass Therapeutics already has institutions on the share registry. ... In addition, we found that Thomas Schuetz, the CEO has 4.0% of the shares allocated to their name. primo by doro handy 413WebView Thomas Schuetz's email address (t*****@compas***.com) and phone number. Thomas works at Compass Therapeutics Llc as Co-Founder and CEO. Thomas is based … primocache 3.0.2 crackedWebUnited States securities and exchange commission logo August 10, 2024 Thomas J. Schuetz, M.D., Ph.D. Chief Executive Officer Compass Therapeutics, Inc. 245 First Street … playstation wrap up statsWebApr 11, 2024 · Insider Activity at Compass Therapeutics. In other news, CEO Thomas J. Schuetz purchased 20,000 shares of the business’s stock in a transaction dated Tuesday, January 31st. playstation アプリ pcWebCompass Therapeutics公司简介,包括公司概况,股票信息,联系电话,及公司业务介绍。 playstation ww2 gamesWebJan 10, 2024 · The first patient has been dosed in the phase 2 study (NCT05513742) of CTX-009 given in the third- or fourth-line setting to patients with metastatic colorectal cancer, according to Compass Therapeutics, Inc. 1 CTX-009 is a bispecific antibody which works by simultaneously blocking Delta-like ligand 4/Notch and vascular endothelial growth factor … playstation year recapWebApr 11, 2024 · Also, CEO Thomas J. Schuetz purchased 10,000 shares of Compass Therapeutics stock in a transaction on Friday, March 10th. The shares were acquired at an average cost of $3.37 per share, for a ... playstation xbox or switch